BNP Paribas REIM has taken a major step forward for its HPF Europe fund (Healthcare Property Fund Europe) with the acquisition of a majority stake in Vita, a landmark Italian healthcare portfolio. The deal strengthens BNP Paribas REIM’s presence in Southern Europe.
In cooperation with their investor clients, including Icade,...
France-headquartered Orphalan, a global pharmaceutical company specialising in the development and commercialisation of orphan drugs, has acquired Orphelia Pharma, a French pharmaceutical company dedicated to rare and serious paediatric diseases, particularly in neurology and oncology.
“Joining forces with Orphalan allows us to expand the reach and impact of our medicines by facilitating and accelerating access to children who need them most,” said Dr Hugues Bienaymé, founder and deputy CEO of Orphelia Pharma.
The acquisition expands Orphalon’s capabilities in rare neurological and oncological paediatric diseases and provides greater reach and improved access...
